Enter your login e-mail to the account
Search
- Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia
MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD.
(2/2023, Review articles ) - Brentuximab vedotin for the treatment of patients with Hodgkin lymphoma
doc. MUDr. Juraj Sokol, PhD., MUDr. Juraj Chudej, PhD., MUDr. Anna Chbat, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD., Prof. MUDr. Ján Staško, PhD.
(1/2022, Drugs & drug classes )
- Inhibitors of factors XI and XII
doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. František Nehaj, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Lenka Lisá, PhD., MUDr. Ľudmila Lineková, MUDr. Ivan Kecskés, MBA, Prof. MUDr. Ján Staško, PhD.
(1/2024, Review articles )